TABLE 3.

Logistic Regression Model for Predictors of VLS in All CALHIV Using DTG-Based ART

Characteristic	OR (95% CI)
Female	0.97 (0.80–1.17)
Average age (SD) in years	0.94 (0.91–0.97)
Average time on ART before DTG (SD) in years	0.99 (0.96–1.01)
Virally suppressed before DTG	3.87 (3.02–4.95)
Any malnutrition	1.03 (0.60–1.77)
History of TB disease	1.58 (0.35–7.16)
Using single tab TLD regimen	1.78 (1.43–2.22)

ART indicates antiretroviral therapy; CALHIV, children and adolescents living with HIV; CI, confidence interval; DTG, dolutegravir; OR, odds ratio; SD, standard deviation; TB, tuberculosis; TLD, tenofovir-lamivudine-dolutegravir fixed drug combination.